FTO and Parkinson disease: Interestingly, the Exo-si-NC administration also significantly decreased FTO, ATM and α-Syn expression levels, but increased TH expression (Fig. 6B–D), showing protective effect on PD as well, despite with relatively lower effectiveness than Exo-si-FTO, indicating that MSC-exo alone may also modulate the m6A modification level in vivo.